The -opioid [D-Ala 2 ,N-Me-Phe 4 ,Gly-ol 5 ]-enkephalin (DAMGO) exerts a peripheral antinociceptive effect against prostaglandin E 2 (PGE 2 )-induced mechanical hyperalgesia in the hindpaw of the rat. Tolerance and dependence develop to this effect. We have shown previously that tolerance and dependence can be dissociated and are mediated by different second messenger systems. In the present study, we evaluated whether the same or different second messenger systems mediate the development of this peripheral opioid tolerance or dependence compared with the expression of the loss of antinociceptive effect or rebound opioid antagonist hyperalgesia (i.e., expression of tolerance and dependence). DAMGO-induced tolerance was prevented by pretreatment with the nitric oxide synthase inhibitor N G -methyl-L-arginine (NMLA) but not by the protein kinase C (PKC) inhibitor chelerythrine, the adenylyl cyclase inhibitor 2Ј,5Ј-dideoxyadenosine (ddA), or the calcium chelators 3,4,5-trimethoxybenzoic acid 8-(diethylamino)-octyl ester (TMB-8) and 2-[(2-bis-[carboxymethyl]amino-5-methylphenoxy)-methyl]-6-methoxy-8-bis[carboxymethyl]aminoquinoline (Quin-2).Once established, however, expression of DAMGO tolerance was acutely reversed by TMB-8 or Quin-2 but not by chelerythrine or NMLA. In contrast, naloxone-precipitated hyperalgesia in DAMGO-tolerant paws, a measure of dependence, was blocked by pretreatment with chelerythrine but not by NMLA, ddA, TMB-8, or Quin-2. Naloxone-precipitated hyperalgesia in DAMGO-tolerant paws was acutely reversed by chelerythrine, ddA, TMB-8, or Quin-2 but not by NMLA. Taken together, these results provide the first evidence that different mechanisms mediate the development and expression of both tolerance and dependence to the peripheral antinociceptive effect of DAMGO. However, although the development of tolerance and dependence are entirely separable, the expression of tolerance and dependence shares common calcium-dependent mechanisms. Opioids, which traditionally are thought to produce analgesia by actions in the C NS, also have antinociceptive actions in the periphery (Levine and Taiwo, 1989;Stein, 1991;Stein et al., 1995). Peripheral analgesic effects of opioids seem to be mediated via -opioid receptors and a G i -and G o -protein-mediated inhibition of the cAM P second messenger system in primary afferent nociceptors (Levine and Taiwo, 1989). We and others have reported previously that tolerance and dependence develop for this peripheral antinociceptive effect of -opioid agonists (Aley et al., 1995;Kolesnikov et al., 1996). In the C NS a number of intracellular pathways have been suggested to play a role in opioid tolerance and dependence (Honore et al., 1997). Among these, Ca 2ϩ (Wang et al., 1996), protein kinase C (Mao et al., 1995a,b;Narita et al., 1995), and nitric oxide (Herman et al., 1995;Pasternak et al., 1995;Vaupel et al., 1995;Dambisya and Lee, 1996;Dunbar and Yaksh, 1996) have been most thoroughly implicated. The mechanisms underlying peripheral opioid tolerance and dependence are...